Loading
Latest filing published 28 Aug 2026 for BioSyent Inc., €7,911. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Stephen Edwin William Wilton is a declared insider of BioSyent Inc., with filings sourced from SEDI. The record holds 3 filings, all for trades on 28 August 2026.
No open-market purchase appears, only 1 sale worth €7,911. The rest of the record consists of 2 option exercises.
The latest filing, published on 28 August 2026, reports an open-market sale of €7,911 in BioSyent Inc. The median gap between trade and publication is zero days: most filings appear on the same day. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations